Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-15 Option Award |
2022-02-17 4:47 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Washington A. Eugene Director |
1,175 | $0 | 26,734 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:47 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | MULCAHY ANNE M Director |
1,175 | $0 | 17,706 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director |
1,175 | $0 | 14,323 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Joly Hubert Director |
1,175 | $0 | 3,614 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | DAVIS D SCOTT Director |
1,175 | $0 | 12,197 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director |
1,175 | $0 | 5,133 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Davis Ian Director |
1,175 | $0 | 17,706 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:46 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director |
1,175 | $0 | 10,355 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:01 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
903 | $0 | 25,494 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
850 | $0 | 25,494 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
8,393 | $165.89 | 25,494 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:01 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
248 | $165.89 | 25,494 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:01 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
18,064 | $0 | 212,285 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
4,053 | $0 | 212,285 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
80,055 | $165.89 | 212,285 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:01 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
8,841 | $165.89 | 212,285 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:01 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer |
3,922 | $0 | 109,257 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer |
3,131 | $0 | 109,257 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer |
61,849 | $165.89 | 109,257 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:01 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer |
1,843 | $165.89 | 109,257 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:01 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
17,793 | $0 | 122,785 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
4,014 | $0 | 122,785 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
79,280 | $165.89 | 122,785 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:01 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
7,319 | $165.89 | 122,785 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:01 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer |
10,386 | $0 | 104,372 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer |
1,530 | $0 | 104,372 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer |
30,214 | $165.89 | 104,372 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:01 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer |
4,699 | $165.89 | 104,372 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:01 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, Medical Devices |
15,806 | $0 | 115,683 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, Medical Devices |
3,347 | $0 | 115,683 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:01 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, Medical Devices |
66,110 | $165.89 | 115,683 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:01 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, Medical Devices |
6,242 | $165.89 | 115,683 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
7,740 | $0 | 85,329 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
3,922 | $0 | 85,329 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
38,736 | $165.89 | 85,329 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
3,366 | $165.89 | 85,329 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
60,965 | $0 | 822,226 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
11,047 | $0 | 822,226 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
218,215 | $165.89 | 822,226 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
26,472 | $165.89 | 822,226 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
22,308 | $0 | 161,185 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
2,190 | $0 | 161,185 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
43,256 | $165.89 | 161,185 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
5,114 | $165.89 | 161,185 (Direct) |
View |
2022-02-14 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
59,428 | $0 | 354,457 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
5,053 | $0 | 354,457 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
99,811 | $165.89 | 354,457 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
12,902 | $165.89 | 354,457 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
2,557 | $0 | 35,818 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
1,830 | $0 | 35,818 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
18,077 | $165.89 | 35,818 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
925 | $165.89 | 35,818 (Direct) |
View |
2022-02-15 Exercise |
2022-02-17 06:00 am |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
13,186 | $0 | 215,261 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
2,575 | $0 | 215,261 (Direct) |
View |
2022-02-14 Option Award |
2022-02-17 06:00 am |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
50,874 | $165.89 | 215,261 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 06:00 am |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
6,209 | $165.89 | 215,261 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:04 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
11,129 | $0 | 552,662 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:04 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
4,833 | $168.85 | 552,662 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:04 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
5,424 | $0 | 229,949 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:04 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
2,356 | $168.85 | 229,949 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:04 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
7,790 | $0 | 227,815 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:04 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
3,133 | $168.85 | 227,815 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:04 pm |
2022-02-12 N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
3,248 | $0 | 27,322 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:04 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
921 | $168.85 | 27,322 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
7,418 | $0 | 37,560 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
2,335 | $168.85 | 37,560 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer |
1,896 | $0 | 65,951 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief GSC Officer |
695 | $168.85 | 65,951 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
2,451 | $0 | 14,035 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
902 | $168.85 | 14,035 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
2,407 | $0 | 153,578 (Direct) |
View |
2021-06-09 Gift |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
912 | $0 | 153,578 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Ullmann Michael H Exec VP, General Counsel |
871 | $168.85 | 153,578 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer |
3,759 | $0 | 41,824 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Consumer |
1,520 | $168.85 | 41,824 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:03 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, Medical Devices |
2,885 | $0 | 35,156 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:03 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, Medical Devices |
792 | $168.85 | 35,156 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:02 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
866 | $0 | 15,510 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
263 | $168.85 | 15,510 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:02 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
2,036 | $0 | 108,636 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
743 | $168.85 | 108,636 (Direct) |
View |
2022-02-14 Exercise |
2022-02-15 8:02 pm |
2022-02-11 N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
3,297 | $0 | 117,233 (Direct) |
View |
2022-02-14 Tax Withholding |
2022-02-15 8:02 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
1,190 | $168.85 | 117,233 (Direct) |
View |
2022-01-14 Tax Withholding |
2022-01-19 8:54 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
150,943 | $167.84 | 546,366 (Direct) |
View |
2021-12-09 Gift |
2022-01-19 8:54 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
6,320 | $0 | 546,366 (Direct) |
View |
2022-01-14 Exercise |
2022-01-19 8:54 pm |
2015-01-17 2022-01-14 |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
231,951 | $65.37 | 546,366 (Direct) |
View |
2022-01-14 Tax Withholding |
2022-01-19 8:54 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
54,378 | $167.84 | 226,874 (Direct) |
View |
2022-01-14 Exercise |
2022-01-19 8:54 pm |
2015-01-18 2022-01-17 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
84,423 | $0 | 226,874 (Direct) |
View |
2022-01-14 Exercise |
2022-01-19 8:54 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO |
84,423 | $65.37 | 226,874 (Direct) |
View |
Ownership |
2022-01-13 5:51 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
0 | $0 | 602,872 (Direct) |
View |
Ownership |
2022-01-13 5:37 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, Chief Information Officer |
0 | $0 | 51,187 (Direct) |
View |
Ownership |
2022-01-13 5:34 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Aff. |
0 | $0 | 92,289 (Direct) |
View |
Ownership |
2022-01-13 4:43 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D |
0 | $0 | 250,624 (Direct) |
View |
2021-12-07 Option Award |
2021-12-09 4:43 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
242 | $161.67 | 4,114 (Direct) |
View |